UK tissue converter Accrol announces all of the resolutions set out in the notice of its annual general meeting were passed by the requisite majority

Sample article from our Tissue & Hygiene

October 19, 2022 (press release) –

Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.

 

Details of the proxy votes received by the Company are as follows:

Resolution

For

Against

Withheld

 

No. of votes

%

No. of votes

%

No. of votes

1.  To receive the Annual Report and Accounts

189,816,491

99.95

103,474

0.05

10,759

2.   To appoint BDO as Auditor

189,621,942

99.84

298,023

0.16

10,759

3.   To approve the Directors' Remuneration Report

179,946,678

94.75

9,973,287

5.25

10,759

4.   To re-elect Simon Allport as a Director

188,359,619

99.28

1,360,346

0.72

210,759

5.   To authorise the Directors to allot relevant securities

189,586,383

99.82

333,582

0.18

10,759

6.   To authorise the Directors to allot equity securities for cash without making a pre-emptive offer to shareholders*

 

189,585,650

 

99.82

 

334,315

 

0.18

 

10,759

*Special resolution

 

Notes:

 

1.

Proxy appointments which gave discretion to the Chairman of the AGM have been included in

"For" total for the appropriate resolution.

2.

Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.

A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.

The number of shares in issue on 18 October 2022 was 318,878,097 with no shares in treasury.

5.

The full text of the resolutions passed at the AGM is available in the Notice of AGM on the Company's website:

https://www.accrol.co.uk/app/uploads/2022/09/22-09-23-Accrol-Notice-of-AGM-Web-1.pdf.

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

 

Richard Newman, Chief Financial Officer

 

 

 

Zeus (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

 

 

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 

 

 

Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

 

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

More from our Tissue & Hygiene Coverage
See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.